Chair: Dag Aarsland, MD
Dag Aarsland, MD, is Professor and Head of Department of Old Age Psychiatry,Institute of Psychiatry, Psychology and Neuroscience at King’s College London, and Research Director at the Centre for Age-Related Medicine, Stavanger University Hospital. As a psychiatrist he has worked as a senior consultant in geriatric psychiatry for most of his career. His main research interest is the neuropsychiatric aspects of patients with neurodegenerative diseases, in particular translational studies on cognitive decline in Parkinson’s disease and dementia with Lewy bodies. He is PI of European DLB Consortium, member of the Scientific board of LBDA, Member of International DLB Consortium, PI of the Western Norwegian Dementia study and the Prodromal LBD study. He has published more than 400 papers in DLB and related areas, including clinical trials, cohort studies, and a wide range of biomarkers including imaging, CSF and EEG.
Vice Chair: Jim Leverenz
Dr. James Leverenz is neurologist and neuropathologist and currently is the Director of the Cleveland site of the Lou Ruvo Center for Brain Health and the Joseph Hahn MD Endowed Chair of the Neurological Institute at the Cleveland Clinic. His clinical and research interests are the aging-associated neurological disorders including the Lewy body dementias, Parkinson’s disease, Alzheimer’s disease, and other neurodegenerative disorders. He serves on the Scientific Advisory Council for the Lewy Body Dementia Association (LBDA) and the LBDA Research Centers of Excellence Management and Industry committees, and is on the Board of Directors and Professional Advisory Board for the Cleveland Chapter of the Alzheimer’s Association. Currently he is the principal investigator for the National Institute of Health (NIH) funded Dementia with Lewy Bodies Consortium and director of the Cleveland Alzheimer’s Disease Research Center. He is also principal- or co-investigator on additional projects funded by the Alzheimer’s Association, Alzheimer’s Drug Discovery Foundation, Department of Defense, Lewy Body Dementia Association and NIH (NIA, NINDS).
Programs Chair: Laura Bonanni
Prof. Bonanni is an Associate Professor in Neurology; Head of Dementia and Movement Disorder's Centre, Neurology Clinic, University of Chieti-Pescara, Italy. She spent significant periods of time in scientific training at first class American Institutions. Laura Bonanni has devoted her research interests to the study of pathophsyiological and diagnostic aspects of Dementia with Lewy Bodies.
Prof. Bonanni is a member of several professional societies and organisations and her leadership roles include coordinating an Italian Network on DLB which now includes 133 dementia centres making it, the largest existing network of its type. She is also on the small executive Steering Group responsible for direction of the recently formed European DLB (E-DLB) Consortium and of the recently constituted ISTAART LBD-Professional Interest Area.
Prof. Bonanni has received conspicuous National and international fundings and important scientific acknowledgments, as a visiting professorship at University of Cincinnati, Ohio, and the designation as Italian leader within the international research on DLB.
Communications Chair: TBA
Executive Committee Member: Bradley Boeve, MD
Dr. Boeve is a consultant in the Department of Neurology and Center for Sleep Medicine at Mayo Clinic in Rochester, Minnesota. He also serves as Chair of the Division of Behavioral Neurology. He holds the academic rank of Professor of Neurology, Mayo Clinic College of Medicine and Science. He is recognized with the distinction of the Little Family Foundation Professorship in Lewy Body Dementia. His clinical and research interests include the non-Alzheimer’s degenerative dementias and the neurologically-based sleep disorders, and particular interests in Lewy body dementia, frontotemporal dementia, and REM sleep behavior disorder. He is a member of the Scientific Advisory Council of the Lewy Body Dementia Association (LBDA), and coordinates the LBDA Research Centers of Excellence program. He is funded by the National Institute on Aging, National Institute of Neurological Disorders and Stroke, the Little Family Foundation, and the Mangurian Foundation. He has coauthored over 500 peer-reviewed papers and over 30 book chapters, and has co-edited 2 books.